Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 16 tags : Trial save search
CNH Industrial to announce an Iveco Group Investor Day on November 18, 2021
Published: 2021-11-16 (Crawled : 22:00) - globenewswire.com
CNHI | $11.275 -1.1% 1M
|
Producer Manufacturing
|
| O: -0.19%
H: 0.0%
C: 0.0%
trial
Atea Pharmaceuticals Provides Update on Strategic Collaboration with RocheAtea to lead global clinical trial development of AT-527 and regain ex-US commercial rights
Published: 2021-11-16 (Crawled : 22:00) - biospace.com/
AVIR | $3.7 -0.8% -0.67% 0
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
at-527 collaboration trial
INDUS Announces Closing on the Acquisition of an Industrial/Logistics Building in Charleston, South Carolina
Published: 2021-11-16 (Crawled : 22:00) - globenewswire.com
INDT 4 | $66.99 0.02% 0.0% 0
|
Real Estate and Rental and Leas...
|
| O: -0.42%
H: 0.98%
C: 0.98%
acquisition trial
Nasal Vaccine Starts Trial to Protect Against Alzheimer's
Published: 2021-11-16 (Crawled : 18:00) - biospace.com/
IMAB | $1.81 0.56% 0.28% 0
|
Health Technology
|
| O: 3.64%
H: 0.0%
C: 0.0%
alzheimer vaccine trial alzheimer’s alzheimer's
PolyPid Appoints New Oncology Advisory Board MemberCompany is Scheduled to Conduct Pre-IND Meeting with the U.S. FDA Later This Month and Potentially Initiate Phase 1/2 Clinical Trial of OncoPLEX for Brain Tumors in 2022
Published: 2021-11-16 (Crawled : 16:00) - biospace.com/
PYPD | $4.5571 1.62% 4.44% 0
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
fda phase 1 potential trial train
Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Published: 2021-11-16 (Crawled : 15:30) - biospace.com/
LLY | News | $732.2 -1.81% -0.71% 8K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
QTRX | $16.04 -0.37% -0.25% 0
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: -1.52%
disease alzheimer clinical trials trials technology research trial conference alzheimer’s alzheimer's disease alzheimer's
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
Published: 2021-11-16 (Crawled : 15:00) - biospace.com/
MYMD | $2.86 11.72% 12.33% 0
|
Manufacturing
|
| O: 1.11%
H: 1.41%
C: -12.72%
fda phase 2 clearance trial
SFIO signs US$100-M Agreement with Omnicor Industrial Estate & Realty Center to Develop a Resort Condotel in Batangas, Philippines
Published: 2021-11-16 (Crawled : 15:00) - globenewswire.com
SFIO | $0.003 56.67% 130K
|
Manufacturing
|
| O: 2.84%
H: 17.24%
C: -12.07%
trial
CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes-Initiation of patient enrollment expected by year-end-
Published: 2021-11-16 (Crawled : 14:00) - biospace.com/
CRSP | News 4 | $53.29 -4.24% 170K
|
Health Technology
|
| O: -5.24%
H: 0.0%
C: 0.0%
crispr diabetes treatment therapy trial enroll
Allied Corp Progresses Towards Clinical Phase I Trial for Psilonex™ RX Psilocybin Pharma Drug
Published: 2021-11-16 (Crawled : 14:00) - globenewswire.com
ALID | $0.19 25K
|
Manufacturing
|
| O: 0.0%
H: 0.96%
C: 0.72%
drug trial pharma psilocybin
INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster Clinical Trial of its Ebola DNA Vaccine Candidate, INO-4201
Published: 2021-11-16 (Crawled : 13:30) - inovio.com
INO | $9.795 -3.59% 22K
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
vaccine trial
Oncotelic Announces Successful Completion of the Safety Evaluation of a TGF-β Inhibitor (OT-101) and IL-2 (Aldesleukin) in Phase 1 Combination Trial in Solid Tumor Cancers
Published: 2021-11-16 (Crawled : 13:30) - globenewswire.com
OTLC | $0.038 5.56% -44.63% 0
|
Manufacturing
|
| O: 4.26%
H: 8.42%
C: 5.92%
phase 1 cancer trial
NAES Corporation Partners with ABS Consulting to Strengthen Industrial Cybersecurity in the Power and Energy Sector
Published: 2021-11-16 (Crawled : 13:00) - prnewswire.com
ITOCF | $44.05 2K
|
Distribution Services
|
| O: -1.33%
H: 0.2%
C: -0.24%
ITOCY | $88.13 1.8% 0.0% 61K
|
Real Estate and Rental and Leas...
|
| O: 0.13%
H: 0.25%
C: 0.01%
security energy cybersecurity trial
Global Industrial IoT Market Research Report (2021 to 2026) - by Technology, Industry and Region
Published: 2021-11-16 (Crawled : 13:00) - prnewswire.com
ABLZF | News | $49.574 2.46% 0
|
Producer Manufacturing
|
| O: -2.07%
H: 0.77%
C: 0.77%
ROK | News | $275.56 -0.28% 0.0% 12
|
Producer Manufacturing
|
| O: 0.18%
H: 2.4%
C: 1.55%
IBM | $166.99 -9.29% 4M
|
Technology Services
|
| O: -0.65%
H: 0.82%
C: -0.39%
HON | News 4 | $193.47 -0.68% 710K
|
Producer Manufacturing
|
| O: 0.0%
H: 0.3%
C: -0.56%
GE | News | $158.06 -0.71% 530K
|
Electronic Technology
|
| O: -1.86%
H: 0.06%
C: -2.64%
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: -0.48%
H: 0.96%
C: 0.6%
PTC | $180.5 0.03% 0.09% 3
|
Technology Services
|
| O: -2.17%
H: 0.0%
C: 0.0%
INTC | $34.645 0.42% 4.9M
|
Electronic Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
CSCO | News | $48.36 0.02% 1.3M
|
Technology Services
|
| O: 0.38%
H: 0.0%
C: 0.0%
ANSS | $327.285 -0.39% 15K
|
Technology Services
|
| O: 0.52%
H: 0.0%
C: 0.0%
technology research iot trial
Kforce Inc. announces participation in the Truist Securities Industrials and Services Summit
Published: 2021-11-16 (Crawled : 13:00) - globenewswire.com
KFRC | $64.08 -0.17% -0.15% 0
|
Commercial Services
|
| O: -0.18%
H: 0.0%
C: 0.0%
trials trial
NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards Clinical Trials
Published: 2021-11-16 (Crawled : 12:00) - biospace.com/
NNVC | $1.15 0.88% -1.74% 600
|
Health Technology
|
| O: -6.11%
H: 0.0%
C: 0.0%
clinical trials trials drug trial
Codiak Reports Positive Initial Data for exoSTING™ Phase 1/2 Trial Indicating Tolerability, Immune Activation, and Evidence of Tumor Shrinkage in Injected and Non-Injected Tumors in the First Three Dose Escalation Cohorts
Published: 2021-11-16 (Crawled : 12:00) - globenewswire.com
CDAK | $0.057 -55.99% -131.25% 0
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: 0.0%
phase 1 positive trial injection
Gainers vs Losers
| 50% | 50% |
Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M
|
Consumer Services
BRFH 4 | $1.99 80.91% 13M
|
Manufacturing
BOF | $1.915 63.68% 620K
|
AMST | $3.13 56.5% 500K
|
Technology Services
ACON | $0.3595 24.83% 3.5M
|
n/a
ILAG | $0.669 23.89% 13M
|
CDTX | News | $14.57 18.55% 330K
|
Health Technology
ULBI M | $10.12 15.92% 120K
|
Producer Manufacturing
LRHC | $1.79 11.88% 3K
|
n/a
AIXI | $1.34 8.94% 42K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.